Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy TELA Bio stock | $16.38

Own TELA Bio stock in just a few minutes.

Fact checked

TELA Bio, Inc is a medical devices business based in the US. TELA Bio shares (TELA) are listed on the NASDAQ and all prices are listed in US Dollars. TELA Bio employs 89 staff and has a trailing 12-month revenue of around USD$17.4 million.

How to buy shares in TELA Bio

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for TELA Bio. Find the stock by name or ticker symbol: TELA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until TELA Bio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$16.38, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of TELA Bio, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of TELA Bio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

TELA Bio share price

Use our graph to track the performance of TELA stocks over time.

TELA Bio shares at a glance

Information last updated 2020-12-11.
Latest market closeUSD$16.38
52-week rangeUSD$5.25 - USD$23.545
50-day moving average USD$16.3443
200-day moving average USD$15.3816
Wall St. target priceUSD$20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy TELA Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy TELA Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TELA Bio price performance over time

Historical closes compared with the close of $16.38 from 2020-12-11

1 week (2021-01-06) N/A
1 month (2020-12-13) N/A
3 months (2020-10-13) N/A
6 months (2020-07-13) N/A
1 year (2020-01-13) N/A
2 years (2019-01-13) N/A
3 years (2018-01-13) N/A
5 years (2016-01-13) N/A

TELA Bio financials

Revenue TTM USD$17.4 million
Gross profit TTM USD$9.6 million
Return on assets TTM -26.38%
Return on equity TTM -133.29%
Profit margin -158.16%
Book value $3.903
Market capitalisation USD$236.7 million

TTM: trailing 12 months

Shorting TELA Bio shares

There are currently 143,379 TELA Bio shares held short by investors – that's known as TELA Bio's "short interest". This figure is 6.2% down from 152,797 last month.

There are a few different ways that this level of interest in shorting TELA Bio shares can be evaluated.

TELA Bio's "short interest ratio" (SIR)

TELA Bio's "short interest ratio" (SIR) is the quantity of TELA Bio shares currently shorted divided by the average quantity of TELA Bio shares traded daily (recently around 18103.409090909). TELA Bio's SIR currently stands at 7.92. In other words for every 100,000 TELA Bio shares traded daily on the market, roughly 7920 shares are currently held short.

However TELA Bio's short interest can also be evaluated against the total number of TELA Bio shares, or, against the total number of tradable TELA Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TELA Bio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 TELA Bio shares in existence, roughly 10 shares are currently held short) or 0.0159% of the tradable shares (for every 100,000 tradable TELA Bio shares, roughly 16 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against TELA Bio.

Find out more about how you can short TELA Bio stock.

TELA Bio share dividends

We're not expecting TELA Bio to pay a dividend over the next 12 months.

TELA Bio overview

TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site